Webinar: Live web braodcast
This presentation will provide an overview of the evidence base for medications employed in a sequential medication treatment algorithm for agitation and aggression in dementia care. It will discuss the purpose, design process and features of this algorithm. The presentation will highlight:
- principles such as the implementation of a drug-free “clean-up” period, and the division of drugs into sequential treatments, PRN treatments, and medications for the underlying disorder
- How the sequential medication treatment algorithm was assembled, taking account not only the strength of evidence for the efficacy in BPSD in treating dementias, but also the side effect profile, complexity of use, efficacy for related conditions and general acceptability to prescribers.
By the end of this presentation, participants will be able to:
- discuss the evidence base for drug treatment of agitation and aggression symptoms in Alzheimer’s/Mixed Vascular Dementia and Fronto-temporal dementia
- outline the process of designing a sequential drug treatment algorithm for agitation and aggression in dementia.
This series is for all health care professionals, allied health care workers and caregivers working with older adults.
Simon Davies, D.M., M.R.C.Psych (UK), M.B.B.S., M.Sc., M.Sc. is a staff psychiatrist in the Geriatrics Program, Late Life Mood and Anxiety Disorders Clinic at CAMH. He is an Assistant Professor, University of Toronto.
Simon trained at Oxford University, UK and worked at the Psychopharmacology Unit, University of Bristol for several years before moving to Toronto. He was the lead designer of the pharmacological sections of the CAMH/SJHC (London, ON) Integrated Care Pathways for the treatment of Agitation and Aggression in Alzheimer’s/Mixed Vascular Dementia and Fronto-temporal Dementia. Simon has published around 60 academic papers in psychiatry, his research interests including drug treatment of anxiety and other psychiatric disorders, the epidemiology of anxiety and depression and characterization of pharmacokinetic interactions of psychotropic drugs.
The continuing education program indicated has been
designated as U of T Accredited and awarded with the following
types of accreditation
- The College of Family Physicians of Canada – 1.5 Mainpro+ credits
- Royal College of Physicians & Surgeons of Canada – 1.5 Section 1 hours
For further information on the webinar series:
Sandra Bennett: email@example.com or firstname.lastname@example.org
Tel: 416.535.8501 Ext. 36732